| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.085 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.15 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.41 | 0.2 |